(Q38410050)

2 September 2017

title

Detection of 2-hydroxyglutarate in formalin-fixed paraffin-embedded glioma specimens by gas chromatography/mass spectrometry (English)

1 reference

2 September 2017

8

Andreas von Deimling

0 references

Stefan Pusch

object named as

Stefan Pusch

3

0 references

Felix Sahm

object named as

Felix Sahm

1

0 references

David Capper

2

object named as

David Capper

1 reference

2 September 2017

7

Jürgen G Okun

1 reference

2 September 2017

5

Arend Koch

1 reference

2 September 2017

4

Jörg Balss

1 reference

2 September 2017

author name string

Claus-Dieter Langhans

6

1 reference

2 September 2017

publication date

16 August 2011

1 reference

2 September 2017

1 reference

2 September 2017

volume

22

1 reference

2 September 2017

issue

1

1 reference

2 September 2017

page(s)

26-31

1 reference

describes a project that uses

2 September 2017

gas chromatography-mass spectrometry

1 reference

based on heuristic

inferred from title

cites work

Analysis of the IDH1 codon 132 mutation in brain tumors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00506.X

IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00506.X

Mutational analysis of D2HGDH and L2HGDH in brain tumours without IDH1 or IDH2 mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00506.X

Monoclonal antibody specific for IDH1 R132H mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00506.X

Application of mutant IDH1 antibody to differentiate diffuse glioma from nonneoplastic central nervous system lesions and therapy-induced changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00506.X

Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00506.X

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00506.X

IDH mutations in glioma and acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00506.X

Rapid and sensitive assessment of the IDH1 and IDH2 mutation status in cerebral gliomas based on DNA pyrosequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00506.X

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00506.X

Identification of several novel non-p.R132 IDH1 variants in thyroid carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00506.X

Detection of IDH1 and IDH2 mutations by fluorescence melting curve analysis as a diagnostic tool for brain biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00506.X

IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00506.X

Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00506.X

IDH2 mutations in patients with D-2-hydroxyglutaric aciduria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00506.X

PCR- and restriction endonuclease-based detection of IDH1 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00506.X

L-2-hydroxyglutaric aciduria and brain malignant tumors: a predisposing condition?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00506.X

An integrated genomic analysis of human glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00506.X

A gene encoding a putative FAD-dependent L-2-hydroxyglutarate dehydrogenase is mutated in L-2-hydroxyglutaric aciduria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00506.X

The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00506.X

IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00506.X

NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00506.X

IDH1 and IDH2 mutations in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00506.X

10.1111/J.1750-3639.2011.00506.X

21 January 2018

Identifiers

DOI

1 reference

2 September 2017

1 reference